doi:10.1136/jitc-2023-007353Drug Therapy, CombinationImmunotherapyProgrammed Cell Death 1 ReceptorTherapies, InvestigationalNon-Small Cell Lung CancerBackground NIS793 is a human IgG2 monoclonal antibody that binds to transforming growth factor beta (TGF-β). This first-in-human study investigated NIS...